SCHEMBL17816165

SCHEMBL17816165

CC1(C)CCC(Sc2cc(C(=O)Nc3ccc(F)c(Cl)c3)ccc2I)CC1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 3/20 0.47
RAB9A P51151 3/20 0.47
MAOB P27338 3/20 0.43
MAOA P21397 2/20 0.43
KMT2A Q03164 4/20 0.43
MEN1 O00255 3/20 0.43
MAPT P10636 3/20 0.43
CASP3 P42574 1/20 0.43
SENP7 Q9BQF6 1/20 0.43
CHRM1 P11229 1/20 0.42
KCNQ3 O43525 1/20 0.42
KCNQ2 O43526 1/20 0.42
KCNE1 P15382 1/20 0.42
KCNQ1 P51787 1/20 0.42
CCR2 P41597 1/20 0.42
ALDH1A1 P00352 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.41
NPSR1 Q6W5P4 1/20 0.40
TAS1R3 Q7RTX0 1/20 0.39
TAS1R1 Q7RTX1 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17816177 0.93 NPC1 (0.47) NPC1RAB9AMAOBMAOAKMT2A
SCHEMBL17784106 0.92 NPC1 (0.50) NPC1RAB9AMAOBMAOAKMT2A
SCHEMBL17816169 0.91 NPC1 (0.47) NPC1RAB9AMAOBMAOAKMT2A
SCHEMBL17816163 0.89 NPC1 (0.44) NPC1RAB9AMAOBMAOAKMT2A
SCHEMBL17816138 0.88 NPC1 (0.50) NPC1RAB9AMAOBMAOAKMT2A
SCHEMBL17816106 0.87 NPC1 (0.49) NPC1RAB9AMAOBMAOAKMT2A
SCHEMBL17816145 0.85 NPC1 (0.49) NPC1RAB9AMAOBMAOAKMT2A
SCHEMBL17792198 0.84 NPC1 (0.50) NPC1RAB9AMAOBMAOAKMT2A
SCHEMBL17816115 0.84 NPC1 (0.48) NPC1RAB9AMAOBMAOAKMT2A
SCHEMBL17816157 0.84 NPC1 (0.53) NPC1RAB9AMAOBMAOAKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2016089990-A1 SULFIDE ALKYL AND PYRIDYL REVERSE SULFONAMIDE COMPOUNDS FOR HBV TREATMENT NOVIRA THERAPEUTICS, INC. (US) 2016-06-09 WO disclosed